(Q40320998)

19 September 2017

title

Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanism (English)

1 reference

cervical intraepithelial neoplasia

19 September 2017

main subject

1 reference

Ramy Ibrahim

1

1 reference

19 September 2017

Helen Frederickson

2

1 reference

19 September 2017

Allyson Parr

3

1 reference

19 September 2017

Yvona Ward

4

1 reference

19 September 2017

Joel Moncur

5

1 reference

19 September 2017

Samir N Khleif

6

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

106

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

1065-1077

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

19 September 2017

1 reference

7 January 2021

Fas ligand is expressed in normal skin and in some cutaneous malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Immunohistochemical analysis of Fas ligand expression in normal human tissues.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Fas and Fas-ligand expression in human pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Fas and the art of lymphocyte maintenance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Immunohistochemical study of Fas, Fas ligand and interleukin-1 beta converting enzyme expression in human prostatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21697

7 January 2021

Identifiers

DOI

10.1002/CNCR.21697

1 reference

19 September 2017

1 reference